Lv1
38 积分 2023-12-19 加入
The role of the natural killer (NK) cell modulation in breast cancer incidence and progress
2天前
已完结
Thirty years since the race to the BRCA1 gene
4天前
已完结
A therapeutic algorithm guiding subsequent therapy selection after CDK4/6 inhibitors’ failure: a review of current and investigational treatment for HR+/Her2- breast cancer
18天前
已完结
Lymph node dissection in small peripheral lung cancer: Supplemental analysis of JCOG0802/WJOG4607L
19天前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
30天前
已完结
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
2个月前
已完结
Towards targeting the breast cancer immune microenvironment
2个月前
已完结
Tackling Osimertinib Resistance in EGFR-Mutant Non–Small Cell Lung Cancer
3个月前
已完结
Response to First-Line Osimertinib Treatment in Non–Small-Cell Lung Cancer With Coexisting G719A and Primary T790M Epidermal Growth Factor Receptor Mutations
7个月前
已关闭
皖公网安备34019202002308
